D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming

BACKGROUND: Combination therapy employing siRNAs and antitumor drugs is a promising method for the treatment of solid tumors. However, regarding combined treatments involving siRNAs and chemotherapeutic reagents, most prior research has focused on the enhanced cytotoxicity against tumor cells confer...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Xi, Fang, Yan, Ren, Yuanyuan, Li, Yinghuan, Wu, Peicheng, Yang, Xiangliang, Liu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391153/
https://www.ncbi.nlm.nih.gov/pubmed/30863058
http://dx.doi.org/10.2147/IJN.S191858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391153/
https://www.ncbi.nlm.nih.gov/pubmed/30863058
http://dx.doi.org/10.2147/IJN.S191858

Ejemplares similares